Background
==========

Tinnitus is defined as the perception of sound in the absence of an external sound source. About one in 10 adults is affected by chronic tinnitus, 20--30 percent of them dealing with considerable effects on daily living \[[@B1]\]. Severe tinnitus is frequently related to comorbidities such as insomnia \[[@B2]\], somatoform disorders, depression \[[@B3]\] or anxiety \[[@B4],[@B5]\]. There have not been many effective treatment options up to now \[[@B6]\]. The best evidence is available for cognitive behavioral therapy so far, which aims to facilitate habituation by improving individual tinnitus coping strategies \[[@B6]-[@B8]\].

Mindfulness-based approaches use meditation techniques and yoga-like elements, and were introduced to clinical medicine about thirty years ago \[[@B9]\]. They have demonstrated efficacy in the treatment of a variety of stress-related disorders \[[@B10],[@B11]\] such as anxiety and mood disorders \[[@B12]\] or chronic pain \[[@B13],[@B14]\]. Very recently, mindfulness-based cognitive therapy has been proposed for the treatment of tinnitus \[[@B15]-[@B18]\]. Mindfulness also constitutes an integral element of the cognitive behavioral treatment programs for tinnitus that have shown convincing results in this indication so far \[[@B17],[@B18]\].

In the current randomized waiting-list-controlled pilot study, we investigated a new manualized therapeutic approach, which is based on mindfulness- and body-psychotherapy and which has been specifically developed for the treatment of tinnitus patients (Tinnitus Atemtherapie) \[[@B19]\]. Essential components of the treatment program include mindfulness, meditation, self-massage, and breathing exercises. These components are intended to help patients use their inner resources to accept responsibility for themselves, become more self-sufficient and develop symptom acceptance.

Methods
=======

Patient recruitment
-------------------

Thirty-six patients with chronic tinnitus (duration ≥ 6 months) were randomized in an experimental group or a waiting list control group of 18 subjects, each after giving written, informed consent to the study. Randomization was conducted applying a computer-generated random list. Clients were recruited by direct referral from a local ENT physician and by an advertisement in the newsletter of the German Tinnitus League. The study was approved by the local ethics committee of the University of Regensburg, Germany (Ethikkommission der Fakultät für Medizin der Universität Regensburg). The study is registered with clinicaltrials.gov (NCT01540357).

Study design
------------

Inclusion criteria were 1) age between 18 and 80 years 2) location in the north-western part of Germany or in Belgium and the ability to understand the German language 3) no communicational problems 4) individual burden caused by subjective tinnitus for at least 6 months and 5) absence of any instable medical conditions. The experimental group was treated with the manualized group therapy; the control group was assessed at the identical time points during a waiting period of 24 weeks before they received treatment. No changes to methods and outcome measures were made after the trial began. Demographical and clinical characteristics of the enrolled patients are provided in Table [1](#T1){ref-type="table"}.

###### 

**Sample characteristics for the whole group and statistical parameters** (**mean** ± **standard deviation**)

                                           **Intervention group**   **Control group**   **Statistics**
  ---------------------------------------- ------------------------ ------------------- -------------------------------
  n                                        18                       18                   
  gender (male/ female)                    11/7                     8/10                χ^2^ = 1.0; df = 1; p = 0.317
  age                                      49.6 ± 8.8               51.7 ± 16.0         t = 0.5; df = 34; p = 0.629
  tinnitus duration                        100.5 ± 119.1            142.3 ± 116.2       t = 1.1; df = 33; p = 0.300
  number of previous treatments            3.4 ± 2.0                3.7 ± 2.1           t = 0.5; df = 33; p = 0.653
  laterality (left, both/central, right)   6, 6, 5                  8, 3, 7             χ^2^ = 1.6; df = 2; p = 0.451
  **Questionnaires**                                                                     
  Tinnitus Questionnaire                   34.1 ± 15.8              37.4 ± 14.9         t = 0.7; df = 34; p = 0.512
  Tinnitus Handicap Inventory              41.0 ± 20.4              45.9 ± 17.7         t = 0.8; df = 34; p = 0.448
  Beck Depression Inventory                11.1 ± 8.1               11.8 ± 7.0          t = 0.3; df = 34; p = 0.793
  **Numeric rating scales**                                                              
  loudness                                 5.7 ± 2.5                6.5 ± 2.2           t = 1.0; df = 34; p = 0.328
  annoyance                                7.2 ± 2.3                5.9 ± 3.0           t = 1.4; df = 33; p = 0.158
  discomfort                               6.9 ± 2.8                7.3 ± 2.3           t = 0.5; df = 34; p = 0.600
  distractibility                          6.2 ± 2.7                6.4 ± 2.7           t = 0.3; df = 34; p = 0.806
  unpleasantness                           5.9 ± 2.8                7.1 ± 2.2           t = 1.4; df = 34; p = 0.169
  **Other** (**no**, **yes**)                                                            
  temporomandibular joint disorder         12, 5                    14, 4               χ^2^ = 0.2; df = 1; p = 0.627
  neck pain                                7, 10                    6, 12               χ^2^ = 0.2; df = 1; p = 0.631
  other pain                               10, 6                    10, 8               χ^2^ = 0.2; df = 1; p = 0.681
  influence of neck movement               12, 4                    9, 9                χ^2^ = 2.2; df = 1; p = 0.134
  psychiatric comorbidity                  12, 5                    14, 4               χ^2^ = 0.2; df = 1; p = 0.627

Treatment program
-----------------

The treatment program includes mindfulness, meditation, self-massage, and breathing exercises as the main components and was developed and manualized \[[@B19]\] by one of the authors (MH). MH is an experienced therapist with a focus on stress-related disorders and also conducted the therapeutic meetings in Aachen, Germany.

Briefly, the treatment consists of (1) meditation elements, (2) imagination exercises, (3) self-massage and individualized gentle movement exercises of the body, (4) exercises aiming at directing moment-to-moment awareness of body- and self- perception and (5) breathing exercises with emphasis on expiration in order to reduce muscle tension and increase relaxation. Participants were taught the therapeutic modules at two weekends (11 hours of treatment/weekend) with an interval of 7 weeks. Two weeks after each weekend and 11 and 15 weeks after the second training weekend patients gathered for a review meeting lasting 2 hours each. Patients were strongly encouraged to perform exercises themselves regularly and were instructed to contact and motivate each other by telephone at least once a week. Data assessment and analysis took place at the University of Regensburg, Regensburg, Germany.

Assessment instruments and statistical analysis
-----------------------------------------------

Tinnitus characteristics were assessed before treatment (baseline), at week 7 (end of second training weekend), at week 9 and week 24 (Figure [1](#F1){ref-type="fig"}). Tinnitus assessments included the German versions of the Tinnitus Handicap Inventory \[[@B20]\], the Tinnitus Questionnaire \[[@B21]\], the Beck Depression Inventory \[[@B22]\], several tinnitus numeric rating scales (loudness, discomfort, annoyance, distractibility, unpleasantness) \[[@B23]\]. Prospective assessment of treatment effects was performed using standardized procedures as established in the Tinnitus Research Initiative (TRI) database \[[@B23]\]. Data management was conducted according to the Data Handling Plan (TRI-DHP Version 06, May 9^th^, 2011). Data analysis was conducted according to the Standard Operating Procedure (TRI-SA Version 01, May 9^th^, 2011), which followed a study-specific Statistical Analysis Plan (SAP-002). All documents are to be found under <http://database.tinnitusresearch.org/>.
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The primary outcome was the change in TQ scores from baseline to week 9. For this purpose, we conducted an analysis of variance (ANOVA) with the within-subjects factor time (screening and week 9) and the between-subjects factor group (intervention vs. control group). Repeated measures ANOVA as used in this study may be confounded with several issues, i.e., low statistical power, regression to the mean due to baseline differences, inflation of type I error due to multiple post hoc tests, etc. \[[@B24]-[@B26]\]. Thus, we controlled for these issues by repeating the primary outcome analysis by calculating an ANCOVA with the between-subjects factor group (intervention vs. control group), with the baseline values of the TQ as covariate, and with TQ score at week 9 as dependent variable. Regression slopes between the covariate and the dependent variable were comparable across conditions (0.848 and 0.864). Secondary outcome measures included chi-square tests for the variables group and treatment response, which was defined as amelioration of at least 5 points in the TQ \[[@B27]\]. In addition, we conducted an additional ANOVA with the factor group and time, this time including four measurement time points (screening, week7, week 9, and week 24). For THI, the numeric rating scales and BDI we performed identical ANOVAs.

Results
=======

The trial was conducted and terminated according to the study protocol priorily defined. No adaption was necessary during the course of the study (April 2010 to December 2010). The groups did not differ significantly in demographical or clinical characteristics as shown in Table [1](#T1){ref-type="table"}.

Three participants did not complete the study procedures. One patient refused to participate after being randomized into the waiting list group; two patients did not return the follow-up-questionnaires after having participated in the meetings without giving any further explanation. These three patients were excluded from our analysis.

ANOVA testing for primary outcome demonstrated a significant interaction effect time by group (F = 7.4; df = 1,33; p = 0.010; η^2^ = 0.183). Post hoc t-tests indicated an amelioration of TQ scores from baseline to week 9 in both groups (intervention group: t = 6.2; df = 17; p \< 0.001; d = 1.458; control group: t = 2.5; df = 16; p = 0.023; d = 0.611) (Figure [2](#F2){ref-type="fig"}), but the intervention group improved at a higher rate than the control group (baseline: t = 0.7; df = 31; p = 0.480; d = 0.249; week 9: t = 2.2; df = 31; p = 0.036; d = 0.764). To account for potential statistical bias (see methods) we redid the primary outcome analysis with an ANCOVA using the baseline values as covariate and TQ score as single dependent variable. Group main effect was again significant (F = 10.948; df = 1,32; p = 0.002; η^2^ = 0.255). The responder rate was higher in the intervention group (14 responders out of 16 subjects) compared to the control group (8 responders out of 17 subjects; χ^2^ = 6.1; df = 1; p = 0.014) with an odds ratio of 7.9 (CI: 1.4-45.8) and a relative risk of 3.5 (CI: 1.0-12.8).
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ANOVA with four measurement time points showed a nearly significant interaction effect time by group (F = 2.2; df = 3,93; p = 0.094; η^2^ = 0.066). Post hoc tests indicated a significant amelioration at week 7, week 9, and week 24 in contrast to baseline for the intervention group (all ts \> 3.1; df = 15; all ps \< 0.008; all ds \> 0.766) and at week 9 and 24 for the control group in contrast to baseline (all ts \> 2.5; df = 16; all ps \< 0.023; all ds \> 0.611). The groups differed at week 7 (t = 1.8; df = 31; p = 0.077; d = 0.638) and 9 (see primary outcome), but not at week 24 (t = 1.2; df = 31; p = 0.257; d = 0.402).

Concordant effects were also found for THI and BDI (see Table [2](#T2){ref-type="table"}). Numeric rating scales did not show significant interaction effects (see Table [2](#T2){ref-type="table"}). Means and standard deviations are provided for all measurements and assessment points in Table [2](#T2){ref-type="table"}.

###### 

**Sample characteristics over all measurement time points and statistical parameters** (**mean** ± **standard deviation**); **n**.**d**. = **not done**

                                                       **Intervention group (df = 15)**   **Control group (df = 16)**   **Intervention vs**. **control group (df = 31)**   **Time by group interaction effect (df = 3,93)**
  ----------------------------- ---------------------- ---------------------------------- ----------------------------- -------------------------------------------------- --------------------------------------------------
  **Questionnaires**                                                                                                                                                        
  Tinnitus Questionnaire        screening              34.6 ± 16.7                        38.5 ± 14.7                   t = 0.7; p = 0.480                                 F = 2.2; p = 0.094
  week 7                        26.4 ± 13.6            35.8 ± 15.5                        t = 1.8; p = 0.077                                                               
  week 9                        22.9 ± 13.0            33.7 ± 15.2                        t = 2.2; p = 0.036                                                               
  week 24                       26.5 ± 16.3            33.1 ± 16.6                        t = 1.2; p = 0.257                                                               
  week 7 vs. baseline           t = −4.3; p \< 0.001   t = −1.4; p = 0.182                                                                                                 
  week 9 vs. baseline           t = −5.4; p \< 0.001   t = −2.5; p = 0.023                                                                                                 
                                week 24 vs. baseline   t = −3.1; p = 0.008                t = −2.7; p = 0.015                                                               
  Tinnitus Handicap Inventory   screening              40.9 ± 21.7                        47.1 ± 17.5                   T = 0.9; p = 0.373                                 F = 4.4; p = 0.006
  week 7                        29.3 ± 17.1            44.8 ± 19.9                        T = 2.4; p = 0.022                                                               
  week 9                        26.3 ± 17.4            41.4 ± 20.0                        T = 2.3; p = 0.027                                                               
  week 24                       27.3 ± 19.9            41.3 ± 21.1                        T = 2.0; p = 0.058                                                               
  week 7 vs. baseline           t = −4.2; p \< 0.001   t = −1.3; p = 0.225                                                                                                 
  week 9 vs. baseline           t = −7.4; p \< 0.001   t = −3.3; p = 0.004                                                                                                 
                                week 24 vs. baseline   t = −5.5; p \< 0.001               t = −2.3; p = 0.037                                                               
  Beck Depression Inventory     screening              11.4 ± 8.4                         12.3 ± 6.9                    t = 0.4; p = 0.732                                 F = 4.4; p = 0.006
  week 7                        8.7 ± 7.6              12.5 ± 6.6                         t = 1.5; p = 0.135                                                               
  week 9                        6.3 ± 4.8              12.1 ± 6.7                         t = 2.9; p = 0.007                                                               
  week 24                       7.6 ± 5.7              13.3 ± 8.7                         t = 2.2; p = 0.035                                                               
  week 7 vs. baseline           t = −2.6; p = 0.019    t = 0.4; p = 0.718                                                                                                  
  week 9 vs. baseline           t = −3.8; p = 0.002    t = −0.2; p = 0.841                                                                                                 
                                week 24 vs. baseline   t = −2.5; p = 0.024                t = 0.8; p = 0.455                                                                
  **Numeric rating scales**                                                                                                                                                 
  loudness                      screening              5.9 ± 2.5                          6.7 ± 2.1                     n.d.                                               F = 1.9; p = 0.135
  week 7                        5.3 ± 2.8              6.6 ± 2.4                          n.d.                                                                             
  week 9                        5.1 ± 2.6              6.8 ± 2.1                          n.d.                                                                             
  week 24                       5.1 ± 2.7              7.0 ± 2.3                          n.d.                                                                             
  week 7 vs. baseline           n.d.                   n.d.                                                                                                                
  week 9 vs. baseline           n.d.                   n.d.                                                                                                                
                                week 24 vs. baseline   n.d.                               n.d.                                                                              
  annoyance                     screening              6.2 ± 3.1                          7.4 ± 2.3                     t = 1.3; p = 0.225                                 F = 2.3; p = 0.087
  week 7                        5.0 ± 2.7              6.9 ± 2.4                          t = 2.2; p = 0.037                                                               
  week 9                        4.6 ± 2.2              7.4 ± 2.1                          t = 3.6; p = 0.001                                                               
  week 24                       5.4 ± 2.6              7.2 ± 2.5                          t = 2.1; p = 0.045                                                               
  week 7 vs. baseline           t = −2.3; p = 0.037    t = −1.6; p = 0.110                                                                                                 
  week 9 vs. baseline           t = −2.5; p = 0.025    t = 0                                                                                                               
                                week 24 vs. baseline   t = −1.5; p = 0.154                t = −0.4; p = 0.683                                                               
  discomfort                    screening              7.1 ± 2.8                          7.6 ± 2.0                     n.d.                                               F = 1.9; p = 0.142
  week 7                        5.3 ± 2.8              7.1 ± 2.3                          n.d.                                                                             
  week 9                        5.5 ± 2.7              7.4 ± 1.8                          n.d.                                                                             
  week 24                       5.6 ± 2.9              7.3 ± 1.9                          n.d.                                                                             
  week 7 vs. baseline           n.d.                   n.d.                                                                                                                
  week 9 vs. baseline           n.d.                   n.d.                                                                                                                
                                week 24 vs. baseline   n.d.                               n.d.                                                                              
  distractibility               screening              6.4 ± 2.8                          6.6 ± 2.6                     n.d.                                               F = 1.9; p = 0.132
  week 7                        5.7 ± 3.0              6.8 ± 3.1                          n.d.                                                                             
  week 9                        5.3 ± 2.8              7.2 ± 2.1                          n.d.                                                                             
  week 24                       5.6 ± 2.7              7.2 ± 2.8                          n.d.                                                                             
  week 7 vs. baseline           n.d.                   n.d.                                                                                                                
  week 9 vs. baseline           n.d.                   n.d.                                                                                                                
                                week 24 vs. baseline   n.d.                               n.d.                                                                              
  unpleasantness                screening              6.2 ± 2.8                          7.0 ± 2.2                     n.d.                                               F = 1.1; p = 0.370
  week 7                        5.4 ± 2.7              6.9 ± 2.5                          n.d.                                                                             
  week 9                        5.4 ± 2.5              7.0 ± 2.2                          n.d.                                                                             
  week 24                       5.4 ± 2.4              7.4 ± 2.0                          n.d.                                                                             
  week 7 vs. baseline           n.d.                   n.d.                                                                                                                
  week 9 vs. baseline           n.d.                   n.d.                                                                                                                
                                week 24 vs. baseline   n.d.                               n.d.                                                                              

The responder rate at week 24 was not statistically higher in the intervention group (11 responders out of 16 subjects) compared to the control group (10 responders out of 17 subjects; χ^2^ = 0.4; df = 1; p = 0.554) with an odds ratio of 1.5 (CI: 0.4-6.5) and a relative risk of 1.3 (CI: 0.6-2.8).

Discussion
==========

The main finding of this pilot study was a significant reduction in the TQ score (baseline vs. week 9) after thirty hours of this new manualized group therapy compared to the waiting list control group. Very recently, first results were presented from a randomized controlled study investigating mindfulness-based therapy in tinnitus patients \[[@B16]\]. Notably, in this previous study neither mindfulness-based therapy nor relaxation training as a control condition exerted an immediate effect on tinnitus symptoms. This might at least in part be due to the large effect already yielded by the preceding psycho-education \[[@B16]\]. However, during the follow-up period mindfulness-based treatment was superior to relaxation therapy \[[@B16]\].

In contrast to this previous study \[[@B16]\], progress tended to stagnate in our study. Clearly, mindfulness-based therapy depends on practice behavior \[[@B16]\]. Thus, the retrogressive effects in our study point to a reduced training maintenance at follow-up and may indicate the relevance of boosting sessions for stabilizing treatment effects.

A pronounced long-lasting effect was also observed in a randomized, controlled study treating chronic tinnitus with a training program lasting five weeks with Qigong \[[@B28]\]. Notably, Qigong had been trained in sessions of 2 hours weekly and one could question the time schedule of two weekends of intensive training of up to 11 hours in our study. Possibly a longer-lasting and repetitive training process would enhance longer-lasting effects through better incorporation of the exercises into daily routine.

Mindfulness-based therapeutic approaches have demonstrated beneficial effects in other stress-related disorders such as chronic pain \[[@B13],[@B29]\] or anxiety \[[@B12]\]. With effect sizes of 0.37 for pain scores \[[@B29]\] and between 0.24 to 0.47 on anxiety scores in patients with chronic medical diseases \[[@B10]\], the effects of mindfulness-based therapies were smaller in those studies when compared to the effect size of 0.80 in our study. However caution is warranted in such comparisons, since further data from larger samples will be needed before the effect size of mindfulness- and body-psychotherapy based treatment in tinnitus can be reliably estimated.

Future studies should also address the specific relevance of the different therapeutic components and their potential neurobiological mechanisms. A significant increase in alpha power through meditation has been revealed by electroencephalographic \[[@B30]\] and magnetencephalographic \[[@B31]\] studies. Alpha power in sensory areas is considered an indicator of inhibitory function \[[@B32]\] and an increase of alpha activity by neurobiofeedback or transcranial magnetic stimulation has been shown to result in reduced tinnitus perception \[[@B33],[@B34]\]. Thus it is tempting to speculate that the beneficial effects of mindfulness- and meditation- based therapy may be mediated by an increase in alpha power. Moreover, brain areas which are known to be involved in tinnitus such as the left hippocampus \[[@B35]\], the posterior cingulate cortex \[[@B36]\], the temporo-parietal junction \[[@B37]\], and the cerebellum \[[@B38]\] have recently been shown to be altered by mindfulness meditation \[[@B39]\].

From a psychological point of view, few studies have focused on the potential mechanisms of mindfulness and acceptance-based training procedures in tinnitus patients, unfortunately. It has been proposed that mindfulness based therapy can facilitate adaptive responses by enhancing cognitive defusion strategies and symptom acceptance connected with a non-evaluative observation of internal events. For example, in a sample of 19 tinnitus patients the frequency of cognitive defusion behaviors and peak level of cognitive defusion as well as peak level of acceptance rated in session 2, predicted a symptom reduction 6 months following treatment, indicating that clients' in-session acceptance and cognitive defusion behaviors appear to play an important role in the reduction of the negative impact of tinnitus \[[@B7]\].

Conclusions
===========

We are well aware of the limiting factors of the pilot study conducted, such as the small sample size, the inherent problems of waiting-list control conditions \[[@B40]\], and the fact that treatment effects may depend on the instructor, which might limit generalization of the results. Nevertheless our pilot data indicate the promise of mindfulness- and body-psychotherapy-based therapy in the treatment of tinnitus and warrant further investigation of its clinical and neurobiological effects in larger studies.
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